Advertisement
Document › Details
Consilium Strategic Communications Ltd.. (9/26/19). "Press Release: Consilium Strategic Communications Expands International Senior Team with Four New Appointments". London & Boston, MA.
Region | United States (USA) | |
Organisation | Consilium Strategic Communications Ltd. | |
Today | ICR Consilium (Consilium Strategic Communications Ltd.) | |
Group | ICR (Group) | |
Organisation 2 | Genmab A/S (CSE: GEN, Nasdaq: GMAB) | |
Group | Genmab (Group) | |
Product | public relations / investor relations / marcom (services) | |
Product 2 | LIFE SCIENCES | |
Person | Curtis Gravesen, Rachel (Consilium Strategic Communications 201909– Senior Strategic Advisor before Genmab + Novo) | |
Person 2 | Elliott, Mary-Jane (Consilium SC 201307– Managing Partner + Co-founder before M:Communications) | |
> Rachel Curtis Gravesen Joins Consilium from Genmab as a Senior Strategic Advisor
> Three Strategic Advisors join Consilium in the US
Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, today announces four new senior appointments: Rachel Curtis Gravesen in Europe and Paul Rabin, Heidi Lorman and Andrea Ziltzer in the US.
Rachel Curtis Gravesen has around 20 years’ experience working in communications and investor relations for some of the world’s leading healthcare companies. Rachel served as Senior Vice President of Investor Relations & Communications at Genmab. Prior to that she worked at Novo Nordisk and had a journalism career spanning almost ten years at the BBC and CNBC. As a Senior Strategic Advisor, Rachel will work with Consilium as it continues to strengthen and expand its healthcare strategic communications offering internationally.
As accomplished veterans in the healthcare communications field, the three new US team members possess deep knowledge across a broad range of therapeutic areas and multiple fields in the life sciences, pharma and biotech industries.
Paul Rabin brings more than 20 years of award-winning media relations experience to the team, having directed and executed successful media PR campaigns for high-profiled clients such as Abbott, Allergan and J&J.
Heidi Lorman provides 20 years of strategic communications counsel through leading strategic campaigns and educational awareness programmes for start-up, mid-size and large companies focused on pharmaceuticals, biotechnology and medical devices.
With more than 25 years of experience in the healthcare industry, Andrea Ziltzer brings expertise in communicating and building relationships with consumers, physicians, advocacy (non-profit) groups, governmental and other influencers.
“I am delighted to welcome Rachel, Paul, Heidi and Andrea to Consilium. Their senior advisor skills, plus years of IR and PR experience and breadth of expertise, will be invaluable to clients on both sides of the Atlantic. Consilium’s dedicated healthcare practice continues to go from strength to strength and we are pleased to be able to continue to grow our team in line with this success.”
Mary-Jane Elliott
Managing Partner of Consilium Strategic Communications
“I am thrilled to be joining the Consilium family. Having known the team for many years, I look forward to working closely with them and the clients both in the US and Europe.”
Rachel Curtis
“Consilium Strategic Communications’ success has been driven by experienced, hard-working, proactive and dedicated healthcare communicators. I am excited to be replicating this in the US with a strong team of experts in their field from media and advocacy relations, digital and social media to corporate, financial and product communications and issues management, giving the company the ability to support clients across the communications spectrum.”
Catherine London
President of Consilium Strategic Communications US Inc
Rachel Curtis can be contacted at curtis@consilium-comms.com
Paul Rabin can be contacted at rabin@consilium-comms.com
Heidi Lorman can be contacted at lorman@consilium-comms.com
Andrea Ziltzer can be contacted at ziltzer@consilium-comms.com
For more information please contact:
Consilium Strategic Communications
Europe
Mary-Jane Elliott / Amber Fennell / Chris Gardner
Tel: +44(0)20 3709 5700
info@consilium-comms.com
www.consilium-comms.com
Follow us: @consiliumhc
US
Catherine London, US President
Tel: +1 917-763-2709
E-mail: London@consilium-comms.com
About Consilium Strategic Communications
Consilium Strategic Communications is an established global leader in strategic healthcare communications and investor relations advisory with operations in London, mainland Europe and the US. Consilium’s specialist team represents a broad range of companies spanning the global healthcare sector and provides strategic, long-term PR and IR advice to companies, funds and charities. Operating with Boards, senior decision makers and executives, we work in partnership with our clients to translate complex healthcare situations into meaningful communications programmes that deliver sustained results, inspire action and build value. For more information, please visit www.consilium-comms.com.
Record changed: 2023-06-05 |
Advertisement
More documents for ICR (Group)
- [1] ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY....
- [2] Consilium Strategic Communications Ltd.. (2/20/23). "Press Release: Consilium Strategic Communications Expands International Presence in US and Europe with Two Senior Strategic Advisor Appointments". London....
- [3] Consilium Strategic Communications Ltd.. (5/6/22). "Press Release: Consilium Strategic Communications Appoints Tracy Cheung as Partner". London....
- [4] OMass Therapeutics Ltd.. (4/28/22). "Press Release: OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases". Oxford....
- [5] Emergex Vaccines Holding Ltd.. (11/18/20). "Press Release: Emergex Vaccines Raises US$11 Million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases". Abingdon....
- [6] Consilium Strategic Communications Ltd.. (11/10/20). "Press Release: Consilium Strategic Communications Strengthens Global Team in the US and Europe". London....
- [7] Consilium Strategic Communications Ltd.. (10/15/20). "Press Release: Consilium Strategic Communications Advises Compass Pathways on Its Successful Initial Public Offering". London....
- [8] Oasmia Pharmaceutical AB. (8/10/20). "Press Release: Oasmia Pharmaceutical Appoints Peter Selin as Chief Business Officer". Uppsala....
- [9] Ascendis Pharma A/S. (8/28/19). "Press Release: Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results". Copenhagen....
- [10] Consilium Strategic Communications Ltd.. (7/10/19). "Press Release: Consilium Strategic Communications Sponsors Future of Healthcare Investor Forum 2019 at London Stock Exchange". London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top